| |
|
|
|
Viking Thera  
|
|
7.15 -0.05 (-0.01%) |
05-29 16:00 |
|
Open: |
7.24 |
Pre close: |
7.2 |
Target:
|
9.52
|
|
High: |
7.3 |
Low: |
6.89 |
Resistance:
|
8.15
9.52
|
|
Volume: |
1,479,240 |
Market Cap: |
519M |
Support:
|
6.34
5.22
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.50
 |
MACD |
MACD(12,26):
|
0.43 |
|
MA(20): |
7.02  |
Signal(12,26,9): |
0.48 |
|
MA(100): |
6.12 |
Stochastic Oscillator |
%K(14,3):
|
52.73 |
|
MA(250): |
6.92 |
%D(3): |
65.29 |
|
Average Volume(K) |
3-Month: |
174998
|
52-Week |
High:
|
8.87 |
|
10-Days: |
169971 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
55.59 |
Change(%): |
-6.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.420 |
Return on Equity (ttm) |
-10.9 |
Shares Out. (M) |
72.60 |
|
EPS Est. Current Year |
-0.830 |
Return on Assets (ttm) |
-8.0 |
Shares Float (M) |
55.88 |
|
EPS Est. Next Year |
-0.800 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.98 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
56.67 |
|
Forward EPS |
-0.360 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
12440 |
|
Book Value (p.s.) |
3.700 |
EBITDA (p.s.) |
0.000 |
P/E |
-17.02 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.93 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.90 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-21.60 |
P/CF |
-20.04 |
|
|
|
|
|
|
